Harvard Combined Orthopedic Residency Program, Harvard Medical School, Boston, MA.
Brigham and Women's Hospital, Boston, MA.
J Hand Surg Am. 2024 May;49(5):490.e1-490.e8. doi: 10.1016/j.jhsa.2022.08.010. Epub 2022 Oct 7.
Rheumatoid arthritis (RA) can have severe impact on patients' functional abilities and increase the risk of fragility fractures. Little is known about how patients with RA fare after operative management of distal radius fractures. The purpose of this study was to compare postoperative complications after surgical fixation in patients with RA and controls, hypothesizing that patients with RA would have higher levels of postoperative complications.
Patients were identified using Current Procedural Terminology and International Classification of Diseases, Ninth and Tenth Revision, codes for open treatment of distal radius fractures and RA at 3 level 1 trauma centers over a 5-year period (2015-2019). Chart abstraction provided details regarding injuries and treatment. Age- and sex-matched controls were identified in a 2:1 ratio. Postoperative complications were classified according to the Clavien-Dindo-Sink classification system and divided into early (less than 90 days) and late groups.
Sixty-four patients (21 with RA and 43 controls) were included. The patients were predominantly women, with a mean age of 62 years and a mean Charlson comorbidity index of 2.1. The RA medications at the time of injury included conventional synthetic disease-modifying antirheumatic drugs (5/21), biologic disease-modifying antirheumatic drugs (5/21), or chronic oral prednisone (6/21). Rheumatoid medications, except hydroxychloroquine, were withheld for 2-3 weeks after surgery. Rheumatoid patients were significantly more likely to sustain a complication compared with the control group, although this was no longer significant on adjusted analysis. Class I complications were the most common. The incidence of early versus late complications was similar between the groups. A high rate of early return to surgery for fixation failure occurred in the RA group compared with none in the control group.
Patients with RA undergoing operative management of distal radius fractures are at risk of postoperative complications, particularly fracture fixation failure, necessitating return to the operative room. High levels of pain, stiffness, and mechanical symptoms were noted in the RA group.
TYPE OF STUDY/LEVEL OF EVIDENCE: Prognostic IV.
类风湿关节炎(RA)会严重影响患者的功能能力,并增加脆性骨折的风险。对于接受桡骨远端骨折手术治疗的 RA 患者的术后转归,我们知之甚少。本研究旨在比较 RA 患者和对照组患者接受手术固定治疗后的术后并发症,假设 RA 患者的术后并发症水平更高。
在 3 家 1 级创伤中心,通过使用当前程序术语和国际疾病分类,第 9 和第 10 修订版代码,在 5 年时间(2015-2019 年)内确定接受开放性桡骨远端骨折治疗和 RA 治疗的患者。病历摘录提供了有关损伤和治疗的详细信息。以 2:1 的比例确定年龄和性别匹配的对照组。根据 Clavien-Dindo-Sink 分类系统对术后并发症进行分类,并分为早期(<90 天)和晚期。
共纳入 64 例患者(21 例 RA 和 43 例对照组)。患者以女性为主,平均年龄 62 岁,Charlson 合并症指数平均为 2.1。受伤时的 RA 药物包括传统合成疾病修饰抗风湿药物(21 例中的 5 例)、生物疾病修饰抗风湿药物(21 例中的 5 例)或慢性口服泼尼松(21 例中的 6 例)。除羟氯喹外,RA 药物在手术后 2-3 周内被停用。与对照组相比,RA 患者发生并发症的可能性显著更高,但在调整分析后这一差异不再显著。I 类并发症最为常见。两组的早期和晚期并发症发生率相似。RA 组中早期因固定失败而再次手术的发生率较高(与对照组相比),而对照组中无一例发生。
接受桡骨远端骨折手术治疗的 RA 患者存在术后并发症风险,尤其是骨折固定失败,需要再次手术。RA 组患者报告了高水平的疼痛、僵硬和机械症状。
研究类型/证据水平:预后 IV 级。